H.S. Ayoub
Contributor since: 2006
Latest Articles
Cephalon's New CLL Drug Should Please Patients and Investors
U.S. No Longer Epicenter of the Financial World
Anavex Life Sciences Takes Cues from FDA in Combating Major Diseases
Allergan Drops Unnecessarily on FDA BOTOX Review
IDM Pharma Jumps 234% After Major "Coincidence"
Somanetics Jumps on Volume Spike
Hepatitis C Developments Drag Biotechs Down
GlaxoSmithKline Heads 2007 Most Ethical Pharmas List
Big Pharma Couples with Biotech: Marriage Made in Hell?
Aoxing Pharmaceutical's Anti-Opioid Addiction Drug Approved by China’s FDA
Protalix Stock Collapses On Unexplained Pricing of New Shares
Inverview With Jonathan Houssian, RxElite Founder: We're "A Significant Growth Investment"
Adventrx Plummets 80% On Cancer Drug Trial Results
Interview: Pluristem Life Systems VP Dr. Prather
Dendreon Has Competition: Northwest BioTherapeutics Gains Cancer Vaccine Approval
Dendreon: Media Spotlight Generates Hype and Hysteria
Dendreon Jumps on New Cancer Vaccine Report
Investment Opportunities In Healthcare: An Interview With Alan Brochstein
Corcept Stock Continues To Rally On Weight Loss News
Why Did Protalix's Stock Offering Announcement Boost Shares?
Are China's Recent Changes In Health Policy A Pre-Olympics Tactic?
Strategic Diagnostics Jumps on Volume Spike
Vion Plunges 60 Percent Following Tuesday's Jump
Tiny Biotech Vion Jumps on Strong Volume, No News
GE Healthcare, Heads Up: Thermogenesis Would Make A Great Buy
ArQule Could Gain Ahead of American Society of Clinical Oncology Meeting
Biotech Buyout Frenzy Continues
Bruker BioSciences Plunges On Market Over-Reaction
Align Technology Blows Past Estimates
AlphaMD: An Investor's Link to the Medical World
Tiny Provectus Pharmaceuticals Jumps 15% on 6x Volume
Oxigene Gains 7% on 10x Volume